Emerging therapeutic agents for onychomycosis

Author： E Piérard Gérald   E Arrese Jorge   Quatresooz Pascale   PiÉrard-Franchimont C  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.3, 2007-09, pp. : 345-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 24, 2015-01 ,pp. : 2819-2857

Bentham Science Publishers

Access to resources Recommend Favorite

Ciclopirox vs oral agents good value in onychomycosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 288, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action

By  

Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. : 433-448

Bentham Science Publishers

Access to resources Recommend Favorite

A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis

By Gupta A.K.  

Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. : 33-52

Adis International

Access to resources Recommend Favorite

Gangliosides: therapeutic agents or therapeutic targets?

By Saragovi H Uri   Gagnon Martin  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 8, 2002-08 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite